-
Mashup Score: 4Fish Oil Diet May Reduce Ki-67 Biomarkers in Prostate Cancer - 3 day(s) ago
A diet high in omega-3 fatty acids and low in omega-6 fatty acids, taken with fish oil, reduced the Ki-67 index in men with prostate cancer on active surveillance.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 4
As someone who has overcome colorectal cancer, I reflect on the support I received from others and vow to continue their legacy of advocacy.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Carrying the Torch: From #ColorectalCancer Survivor to Advocate #PatientAdvocacy @jbullock114 https://t.co/cN8dSk8uxo
-
-
Mashup Score: 5
A phase 2a trial of IMM-1-104 plus chemotherapy demonstrated efficacy and tolerability in first- and second-line pancreatic cancer.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
IMM-1-104 Treatment May Improve Responses in #PancreaticCancer @GIcancerDoc @MayoClinic #pancsm #oncology https://t.co/ZhPb4dQiqS
-
-
Mashup Score: 3
An expert spoke with CURE® about the emotional bonds that can develop while treating patients with cancer.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Kate, Princess of Wales, ‘Got So Attached’ to Her Port During Cancer Treatment @DrFrankJPenedo @SylvesterCancer @RoyalFamily @royalmarsdenNHS #Oncology #MedTwitter https://t.co/34KVWR822a
-
-
Mashup Score: 0Waiting for Results After My CLL Diagnosis - 3 day(s) ago
Waiting for results of a CT scan after a cancer diagnosis is agonizing, as I anxiously await news on whether my disease has returned.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Waiting for Results After My CLL Diagnosis #ChronicLymphocyticLeukemia https://t.co/1zegMIj1fV
-
-
Mashup Score: 1
Ten days of subcutaneous Dacogen resulted in responses among a third of patients with myelofibrosis.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Subcutaneous Dacogen Elicits Responses Among Some With #Myelofibrosis @BalazsHalmosMD @USA_FDA https://t.co/veTgIPSLrX
-
-
Mashup Score: 2
Patients with relapsed or refractory multiple myeloma should consider quality of life with survival when choosing the most suitable treatment option.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Before deciding on a treatment regimen for relapsed or refractory multiple myeloma, it's important for patients to talk to their doctors about any quality of life considerations, according to Dr. Henry Fung of @FoxChaseCancer. #MMSM Read more: https://t.co/00u4OkhOus
-
-
Mashup Score: 0
Dr. Balazs Halmos discusses the significance of the approval of subcutaneous Opdivo and what this treatment formulation means for those with solid tumors.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
The Significance of the Subcutaneous Opdivo FDA Approval in Solid Tumors @BalazsHalmosMD @EinsteinMed @US_fda #Oncology #MedTwitter https://t.co/JahkVywwH4
-
-
Mashup Score: 0
The Food and Drug Administration has accepted and granted priority review to a new drug application for sunvozertinib.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
FDA Grants Priority Review to Sunvozertinib for EGFR Exon20+ NSCLC. #NSCLC #EGFR @Dizal_Global https://t.co/V3bo9pj338
-
-
Mashup Score: 0
Treatment with fixed-dose subcutaneous Sarclisa plus Pomalyst and dexamethasone was non-inferior to IV Sarclisa in relapsed/refractory multiple myeloma.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
Fixed-Dose Subcutaneous Sarclisa Combo is Non-Inferior to IV Sarclisa in R/R #Myeloma @MayoClinic #mmsm #oncology https://t.co/5JB5WwfvjJ
-
Fish Oil Diet May Reduce Ki-67 Biomarkers in #ProstateCancer. #FishOils @JCO_ASCO https://t.co/g4chM2dlWo